Medclair AB (NGM:MCLR)

Medclair AB Statistics

Total Valuation

Medclair AB has a market cap or net worth of SEK 244.70 million. The enterprise value is 238.96 million.

Market Cap	244.70M
Enterprise Value	238.96M

Important Dates

The last earnings date was Friday, February 20, 2026.

Earnings Date	Feb 20, 2026
Ex-Dividend Date	n/a

Share Statistics

Medclair AB has 91.65 million shares outstanding. The number of shares has decreased by -90.99% in one year.

Current Share Class	91.65M
Shares Outstanding	91.65M
Shares Change (YoY)	-90.99%
Shares Change (QoQ)	-11.55%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

The trailing PE ratio is 4.45.

PE Ratio	4.45
Forward PE	n/a
PS Ratio	4.36
PB Ratio	4.56
P/TBV Ratio	12.32
P/FCF Ratio	n/a
P/OCF Ratio	34.97
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	51.36
EV / Sales	4.26
EV / EBITDA	24.82
EV / EBIT	51.71
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.06

Current Ratio	3.06
Quick Ratio	1.64
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	9.53

Financial Efficiency

Return on equity (ROE) is 9.06% and return on invested capital (ROIC) is 9.06%.

Return on Equity (ROE)	9.06%
Return on Assets (ROA)	4.79%
Return on Invested Capital (ROIC)	9.06%
Return on Capital Employed (ROCE)	8.61%
Weighted Average Cost of Capital (WACC)	9.64%
Revenue Per Employee	4.00M
Profits Per Employee	332,357
Employee Count	14
Asset Turnover	0.93
Inventory Turnover	2.65

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +78.00% in the last 52 weeks. The beta is 0.98, so Medclair AB's price volatility has been similar to the market average.

Beta (5Y)	0.98
52-Week Price Change	+78.00%
50-Day Moving Average	2.87
200-Day Moving Average	2.64
Relative Strength Index (RSI)	40.65
Average Volume (20 Days)	83,500

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medclair AB had revenue of SEK 56.07 million and earned 4.65 million in profits. Earnings per share was 0.60.

Revenue	56.07M
Gross Profit	38.04M
Operating Income	4.62M
Pretax Income	4.65M
Net Income	4.65M
EBITDA	9.63M
EBIT	4.62M
Earnings Per Share (EPS)	0.60

Balance Sheet

The company has 5.74 million in cash and n/a in debt, with a net cash position of 5.74 million or 0.06 per share.

Cash & Cash Equivalents	5.74M
Total Debt	n/a
Net Cash	5.74M
Net Cash Per Share	0.06
Equity (Book Value)	53.69M
Book Value Per Share	0.65
Working Capital	14.42M

Cash Flow

Operating Cash Flow	7.00M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 67.85%, with operating and profit margins of 8.24% and 8.30%.

Gross Margin	67.85%
Operating Margin	8.24%
Pretax Margin	8.30%
Profit Margin	8.30%
EBITDA Margin	17.17%
EBIT Margin	8.24%
FCF Margin	n/a

Dividends & Yields

Medclair AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	90.99%
Shareholder Yield	90.99%
Earnings Yield	1.90%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	7